Hisse detayları

Türk İlaç ve Serum Sanayi A.Ş.

TRILCSTOCKS | TR | IST | Healthcare | Drug Manufacturers - Specialty & Generic

Profil özetiTRY 0.8Piyasa değeri TRY 798.5M

No local candle data found.

Son tespit edilen formasyonlar / setup’lar

Bu sembol ve seçili yön için son 10 Market Radar sonucu.

FormasyonTFTarama çalışmasıKalite

BullishOliver Kell Momentum Setup15M07 Nov 26, 09:1479

BullishICT Inverse FVG Setup15M07 Nov 26, 09:1486

BullishICT FVG Setup15M07 Nov 26, 09:14100

BullishOliver Kell Momentum Setup4H06 Nov 26, 16:1777

BullishICT FVG Reaction Setup4H + 15M06 Nov 26, 16:1792

BearishICT Inverse FVG Setup4H06 Nov 26, 16:1797

BullishICT FVG Setup4H06 Nov 26, 16:17100

BearishICT FVG Reaction Setup1D + 15M06 Nov 26, 16:1797

BullishICT Inverse FVG Setup1D06 Nov 26, 16:17100

BullishICT FVG Setup1D06 Nov 26, 16:17100

TRILC şirket profili

Türk İlaç ve Serum Sanayi A.Ş. (TRILC), IST borsasında işlem görür. Sektör: Healthcare. Faaliyet alanı: Drug Manufacturers - Specialty & Generic.

Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids, and other chemicals in Turkey. It also offers bulb, biological, and serum products, as well as medical devices. Turk Ilac Ve Serum Sanayi Anonim Sirketi was founded in 2010 and is headquartered in Ankara, Turkey.

Şirketin faaliyet açıklaması veri sağlayıcısından özgün dilinde sunulmaktadır.

Yıllık

Yıllık temel veriler

2025 ve önceki yıllık dönem

Toplam gelirTRY 4.5B+35.3%

Net gelirTRY -622.6M-757.4%

Net kâr marjı-13.7%-16.5 pp

Hisse başına kâr-0.6-752.5%

Toplam borçTRY 3.4B+56.5%

Nakit ve nakit benzerleriTRY 11.3M+24.9%

Net borçTRY 3.4B+56.7%

Metrik20212022202320242025

Toplam gelirTRY 672.6M--TRY 1.6B+143.4%TRY 2.8B+69.5%TRY 3.4B+20.9%TRY 4.5B+35.3%

Net gelirTRY 37.1M--TRY -81.7M-319.9%TRY 152.6M+286.9%TRY 94.7M-37.9%TRY -622.6M-757.4%

Net kâr marjı5.5%---5.0%-190.3%5.5%+210.3%2.8%-48.7%-13.7%-585.9%

Hisse başına kâr0.04---0.08-319.6%0.15+286.1%0.09-37.2%-0.6-752.5%

Serbest nakit akışıTRY -92.3M--TRY 109.5M+218.7%TRY 292.9M+167.4%TRY -688.6M-335.1%TRY 357.8M+152.0%

Toplam borçTRY 197.2M--TRY 511.7M+159.4%TRY 619.8M+21.1%TRY 2.2B+248.3%TRY 3.4B+56.5%

Nakit ve nakit benzerleriTRY 44.8M--TRY 10M-77.6%TRY 8.1M-19.4%TRY 9M+12.0%TRY 11.3M+24.9%

Net borçTRY 152.4M--TRY 501.6M+229.1%TRY 611.7M+21.9%TRY 2.1B+251.5%TRY 3.4B+56.7%

Çeyreklik

Çeyreklik temel veriler

Q2 2026 ve geçen yılın aynı çeyreği

Toplam gelirTRY 1.5B+10.1%

Net gelirTRY -105.8M-151.0%

Net kâr marjı-6.9%-21.9 pp

Hisse başına kâr----

Toplam borçTRY 4.3B+4.2%

Nakit ve nakit benzerleriTRY 15.7M-65.3%

Net borçTRY 4.3B+5.0%

MetrikQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Toplam gelir----TRY 732M--TRY 1.2B--TRY 1.8B+110.0%TRY 1.4B--TRY 1.5B+108.9%

Net gelir----TRY -251.9M--TRY 119M--TRY -128M-3850.4%TRY 207.6M--TRY -105.8M+58.0%

Net kâr marjı-----34.4%--10.2%---6.9%-1885.6%14.9%---6.9%+79.9%

Hisse başına kâr-0.38---0.24--0.12------0.2+152.7%----

Serbest nakit akışı----TRY -479.7M--TRY 635.9M--TRY 208.9M+88.7%TRY -737.2M--TRY -114.1M+76.2%

Toplam borç----TRY 2.3B--TRY 2.7B--TRY 3.4B+104.9%TRY 4.1B--TRY 4.3B+88.9%

Nakit ve nakit benzerleri----TRY 17.7M--TRY 12.4M--TRY 11.3M+63.4%TRY 45.1M--TRY 15.7M-11.4%

Net borç----TRY 2.3B--TRY 2.7B--TRY 3.4B+105.1%TRY 4.1B--TRY 4.3B+89.7%

Sahiplik

Kurumsal sahiplik özeti

2026 Q3, quarter ended 2026-08-21

PeriodSahiplikKurumlar13F paylarıToplam yatırımPozisyonlar